https://www.selleckchem.com/pr....oducts/bgb-283-bgb28
Surgical site infection represents the most severe complication in prosthetic breast reconstruction. Risk profiling represents a useful tool for both clinicians and patients. In our hospital, 534 breast reconstructions with tissue expander implants, in 500 patients, were performed. Several clinical variables were collected. In our study, we evaluated the different inflammatory markers present in the periprosthetic fluid and we compared them with the ones present in plasma. The surgical site infection rate resulted to be 10.5%, an
Like
Comment
Share
